The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of
companies/institutions engaged in the Healthcare Services Sector. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.
This product is suitable for investors who are seeking
• Long term capital growth
• Investment in equity instruments of companies in the Pharma & Healthcare sectorHigh Risk Level